Information  X 
Enter a valid email address

Primary Health Props (PHP)

  Print   

Monday 17 May, 2021

Primary Health Props

Application for listing and total voting rights

RNS Number : 8712Y
Primary Health Properties PLC
17 May 2021
 

Primary Health Properties PLC

("PHP" or the "Company")

 

Application for listing and total voting rights

 

In connection with the scrip dividend offer made in respect of the second quarterly interim dividend for 2021 of 1.55 pence per ordinary share announced on 25 March 2021 ("Scrip Offer"), the Company announces that it has received valid elections from shareholders holding a total of 204,596,483 ordinary shares of 12.5p each in the capital of the Company ("Ordinary Shares") resulting in a requirement to issue 1,964,945 new Ordinary Shares ("New Shares").  

PHP has therefore made application for the New Shares to be issued in connection with the Scrip Offer to be admitted to the premium segment of the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange respectively.  

Admission of the New Shares is expected to be effective on 21 May 2021.  Following admission and in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority, the Company will have 1,330,216,598 Ordinary Shares in issue, each share carrying the right to one vote. The Company does not hold any shares in treasury.

The above figure of 1,330,216,598 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

For further information:

 

 

Primary Health Properties PLC

Paul Wright, Company Secretary    +44(0) 20 7451 7050

 

LEI: 213800Y5CJHXOATK7X11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSGPURUAUPGGPM

a d v e r t i s e m e n t